Tuesday, October 4th, 2016
04:30 PM - 06:00 PM
Stamford CampusStamford Innovation Center 175 Atlantic Street
The Program in Innovative Therapeutics for Connecticutâs Health, also known as PITCH, will create new biotech companies in Connecticut based on CTâs academic biomedical research.
Building on significant academic infrastructure and experienced leadership bridging the worlds of academia, biopharma and venture capital, the PITCH program will educate and guide the stateâs academic researchers to unlock Connecticutâs large potential for biotech/biopharma creation.
Hosted by Susan Froshauer, Ph.D., President and CEO of CURE.
â¢ Janie Merkel, Ph.D., Director of the PITCH program
â¢ John C. Deacon, Ph.D., Associate Research Scientist, Yale University
â¢ Michael Lynes, Ph.D., Head of the Department of Molecular and Cell Biology at the University of Connecticut